BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Wisconsin Cancer Collaborative - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://wicancer.org
X-WR-CALDESC:Events for Wisconsin Cancer Collaborative
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Chicago
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20200308T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20201101T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20210314T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20211107T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20220313T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20221106T070000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20210812T100000
DTEND;TZID=America/Chicago:20210812T110000
DTSTAMP:20260430T154327
CREATED:20210707T175049Z
LAST-MODIFIED:20210707T175049Z
UID:10243-1628762400-1628766000@wicancer.org
SUMMARY:WCC Monthly Webinar: The Financial Toxicity of Cancer: Causes\, Effects\, and Potential Solutions
DESCRIPTION:The Financial Toxicity of Cancer: Causes\, Effects\, and Potential Solutions\n\n\n\n\nAugust 12\, 2021 | 10-11 am\n\n\n\n\n\nCancer is one of the most expensive medical conditions a person can experience. From the time of diagnosis through end of life\, cancer can create severe financial distress for patients and their loved ones. This financial distress can take a toll on physical and psychological well-being\, and it can negatively affect patient outcomes. \nLearn more about what contributes to financial toxicity; how it impacts patients\, survivors\, and families; and how we might reverse this troubling phenomenon. \nRegister Here: https://uwmadison.zoom.us/meeting/register/tJMsfuipqDssE9PfiioJrwOw965ff2xPUPHM
URL:https://wicancer.org/event/wcc-monthly-webinar-the-financial-toxicity-of-cancer-causes-effects-and-potential-solutions/
LOCATION:Webinar/Web Conference
ORGANIZER;CN="Wisconsin Cancer Collaborative":MAILTO:osteidl@wisc.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20210812T130000
DTEND;TZID=America/Chicago:20210812T140000
DTSTAMP:20260430T154327
CREATED:20210811T144714Z
LAST-MODIFIED:20210811T144714Z
UID:10365-1628773200-1628776800@wicancer.org
SUMMARY:Therapeutic Options to Prevent Severe COVID-19 in Immunocompromised People
DESCRIPTION:Overview\nThe U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorizations (EUA) for monoclonal antibodies to treat COVID-19 for certain patients. Monoclonal antibodies may be available through expanded access programs to treat COVID-19 for immunocompromised patients. However\, the efficacy of use for immunocompromised patients is unclear. \nDuring this COCA Call\, presenters will discuss the FDA’s role in issuing EUAs for certain monoclonal antibodies\, options for compassionate use\, the process for ordering and distributing monoclonal antibodies\, and current data on using monoclonal antibodies for both non-hospitalized and immunocompromised patients. Presenters will also cover preventing\, diagnosing\, and treating COVID-19 in immunocompromised patients\, including the role of monoclonal antibodies\, serologic testing\, and potential third dose of COVID-19 vaccinations. \n\n\n\n\nPresenters\nElliot Raizes\, MD\nTask Force Lead\nHealth Services and Worker Safety Task Force\nCOVID-19 Response\nCenters for Disease Control​ and Prevention \nJohn Farley\, MD\, MPH\nDirector\, Office of Infectious Diseases\nCenter for Drug Evaluation and Research\nOffice of New Drugs\nU.S. Food and Drug Administration \nColin Shepard\, MD\nCDC Liaison to the Assistant Secretary for Preparedness and Response (ASPR)\nCenter for Preparedness and Response\nCenters for Disease Control and Prevention \nRajesh Gandhi\, MD\nDirector\, HIV Clinical Services and Education\, Massachusetts General Hospital\nProfessor of Medicine\, Harvard Medical School \nAdi V. Gundlapalli\, MD\, PhD\nCo-Lead\, Serology and Correlates of Protection Tiger Team\, COVID-19 Response\nChief Public Health Informatics Officer\nCenter for Surveillance\, Epidemiology\, and Laboratory Services\nCenters for Disease Control and Prevention
URL:https://wicancer.org/event/therapeutic-options-to-prevent-severe-covid-19-in-immunocompromised-people/
LOCATION:Webinar/Web Conference
END:VEVENT
END:VCALENDAR